Balyasny Asset Management
OM icon

Balyasny Asset Management’s Outset Medical OM Stock Holding History

Balyasny Asset Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-116,291
Closed -$1.64M – 3429
2025
Q3 		$1.64M Sell
116,291
-26,869
-19% -$419K ﹤0.01% 1899
2025
Q2 		$2.75M Buy
+143,160
New +$2.23M ﹤0.01% 1572
2024
Q3 		– Sell
-1,124
Closed -$64.9K – 3036
2024
Q2 		$64.9K Buy
+1,124
New +$55.1K ﹤0.01% 2427
2022
Q1 		– Sell
-3,947
Closed -$2.73M – 2739
2021
Q4 		$2.73M Buy
+3,947
New +$2.92M 0.01% 1091

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Balyasny Asset Management's OM Position: Q4 2025 in Review

Balyasny Asset Management sold out of Outset Medical (OM) in Q4 2025, closing a stake of 116,291 shares — an estimated $1.64M sold.

Balyasny Asset Management first reported a position in OM in Q4 2021 and held it in 4 quarters. The position peaked at $2.75M in Q2 2025. 100 funds tracked by Wall St. Rank hold OM as of Q4 2025.

  • Balyasny Asset Management reported no remaining Outset Medical position as of Q4 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 116,291 Outset Medical shares in Q4 2025, an estimated $1.64M.
  • Balyasny Asset Management first reported a position in Outset Medical in Q4 2021 and held it in 4 quarters.
  • Balyasny Asset Management's Outset Medical position peaked at $2.75M in Q2 2025.
  • 100 funds tracked by Wall St. Rank held Outset Medical as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.